(10% Negative) Kiniksa Pharmaceuticals (KNSA) Announces Delay in million Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Kamke Trent G 🟡 adjusted position in 0 shares (2 derivative) of LEMAITRE VASCULAR INC (LMAT) at $48.60 Transaction Date: Jan 08, 2026 | Filing ID: 010637